[LABP] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
23-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 51.27%
YoY- 80.69%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,860 -3,922 -6,034 -5,232 -7,896 -11,284 -14,864 -46.20%
Tax 0 -557 -445 -1,352 67 18 -89 -
NP -5,860 -3,922 -5,589 -3,880 -7,963 -11,302 -14,775 -45.98%
Tax Rate - - - - - - - -
Total Cost 5,860 3,922 5,589 3,880 7,963 11,302 14,775 -45.98%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.94 -0.63 -0.86 -0.96 -1.98 -2.81 -3.67 -59.63%
EPS Diluted -0.94 -0.63 -0.86 -0.96 -1.98 -2.81 -3.67 -59.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.